CA2082186A1 - Production of high binding capacity magnetizable particles of controlled size used in immunoassay systems - Google Patents
Production of high binding capacity magnetizable particles of controlled size used in immunoassay systemsInfo
- Publication number
- CA2082186A1 CA2082186A1 CA 2082186 CA2082186A CA2082186A1 CA 2082186 A1 CA2082186 A1 CA 2082186A1 CA 2082186 CA2082186 CA 2082186 CA 2082186 A CA2082186 A CA 2082186A CA 2082186 A1 CA2082186 A1 CA 2082186A1
- Authority
- CA
- Canada
- Prior art keywords
- particles
- silane
- binding capacity
- ratio
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002245 particle Substances 0.000 title claims abstract description 78
- 238000004519 manufacturing process Methods 0.000 title abstract description 13
- 230000027455 binding Effects 0.000 title abstract description 8
- 238000003018 immunoassay Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 36
- 230000008569 process Effects 0.000 claims abstract description 25
- 229910000077 silane Inorganic materials 0.000 claims abstract description 22
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims abstract description 17
- 150000001412 amines Chemical class 0.000 claims description 10
- 239000006249 magnetic particle Substances 0.000 claims description 9
- JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 claims description 8
- 238000003556 assay Methods 0.000 claims description 8
- 230000000984 immunochemical effect Effects 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 3
- 239000003463 adsorbent Substances 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 claims description 3
- 238000002835 absorbance Methods 0.000 claims description 2
- 150000003973 alkyl amines Chemical class 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical group CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims 1
- 230000005298 paramagnetic effect Effects 0.000 abstract description 8
- 238000002444 silanisation Methods 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 5
- 231100001261 hazardous Toxicity 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 8
- 238000004062 sedimentation Methods 0.000 description 7
- -1 silane amine Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 102000011923 Thyrotropin Human genes 0.000 description 6
- 108010061174 Thyrotropin Proteins 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000005291 magnetic effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241001635598 Enicostema Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960002089 ferrous chloride Drugs 0.000 description 2
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 2
- 159000000014 iron salts Chemical class 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- 101100087530 Caenorhabditis elegans rom-1 gene Proteins 0.000 description 1
- 240000003550 Eusideroxylon zwageri Species 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 101100305983 Mus musculus Rom1 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
- 102100026456 POU domain, class 3, transcription factor 3 Human genes 0.000 description 1
- 101710133393 POU domain, class 3, transcription factor 3 Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- YGUFXEJWPRRAEK-UHFFFAOYSA-N dodecyl(triethoxy)silane Chemical compound CCCCCCCCCCCC[Si](OCC)(OCC)OCC YGUFXEJWPRRAEK-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- CZWLNMOIEMTDJY-UHFFFAOYSA-N hexyl(trimethoxy)silane Chemical compound CCCCCC[Si](OC)(OC)OC CZWLNMOIEMTDJY-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002907 paramagnetic material Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 108010072897 transcription factor Brn-2 Proteins 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Abstract High binding capacity magnetized particles, which represent a significant improvement over the existing paramagnetic particles, were developed. It was found that the use of high pH silanization yields particles that maintain the original size throughout the manufacturing process. These exhibit good binding capacity and do not require the use of hazardous solvents during manufacture. Also, it was found to be a more efficient process, in that an 80 - 90%
reduction in the use of silane was realized.
reduction in the use of silane was realized.
Description
2~2~8~ ~
PRODUC'~ION OF HIGH BINDING CAPACITY MAGNETIZABLE PARTIC~ES
OF CONTROLLED SIZE USED IN IM~NOASSAY SYSTEMS
Backaround The use of magnetic particles for biochemical separations has been known for some time. (U.S. Patents ~,554,088;
4,628,037; ~,695,392; 4,695,393; Hersh, L.S., Yaverbaum, S., Magnetic Solid-Phase Radioimmunoassay, 63 Clin. Chim. Acta (1975) 69; Pourfarzaneh, M., Johnson, S.C., Landon, J., Production and Use of ~agnetizable Particles in Immunoassay, 5 The ~igand Quarterly (~82~ 41.) They are particularly use~ul in the separation of immwlochemical complexes, in which one of the members of the immunochemical pair (i.e., either the antigen or antibody) is coupled to the magnetic particle. When this parti¢le complexes to the other member of the i~munochemical pair, the complex is then easily separated from the solution by the use of a ma~net.
The Whitehead patents co~er the coatPd iron oxide particles :~
themselves (U.S~ Patent No. 4,695,392), the particles coupled to a ~ioaffinity adsorbent ~U.S. Patent No~
4,S54,088), the use of the particles for determining the concentration of a ligate (U.S. Patent No. 4,628,037~, and the process for preparing the magnetically-responsive particles ~V~SO Patent No. 4,69S,393).
: ' The existing (Whitehead) process for preparing these 2~82:~g~
particles involves the use of acidic pH conditions (pH 4.5), to which a 10~ silane amine solution is added, with the mixture heated at 90 - ~5 QC for about 2 hours followed by a glycerol dehydration step and a wash of the final product with copious amounts of methanol and water. This results in a decrease in particle size and a corresponding decrease in sedimentation rate for the particles. ln addition, the existing process involves the use of hazardous solvents (e.g., methanol) and, therefore, requires the use of special facilities and equipment (to reduce the risk from possible explosion) and the need to take precautions regarding the disposal or recycling of the spent solvent.
Summary High binding capacity magnetized particles, which represent a significant improvament over the existing paramagnetic particles, were developed. It was found that the use of high pH silanization yields particles that maintain the original size throughout the manufacturing process. These exhi~it good binding capacity and do not require the use of hazardous solvents during manufacture. Also, it was found to be a more efficient process, in that an 80 - 90%
reduction in the use of silane was realized.
Details of the Invention This invention rslates to an improvement in the process for making paramagnetic particles which are useful in ~;
biochemical separations. One major use is in immunochemical assays, wherein a biochemically active species (e.g., an antibody) is chemically bound to the paramagnetic particle.
After the paramagnetic particle-antibody complex has reacted with any antigen in solution, the presence of the paramagnetic material simplifies the separation of the - . ~
2~2~
antigell-antibody complex for further analysis. Other applications, for example, in affinity purification chromatography, are known for these paramagnetic particles by those experienced in the art.
Although paramagnetic particles made of iron salts are prefPrred, particles made from any material or combination of materials having magnetic properties can be used in the novel process for making coated magnetic particles. For example, chromium salts or mixtures of iron salts and glass can be used in the process.
It was found that, by conducting the silanization process in a high pH environment, an unexpected benefit was found, in that relatively high binding capacity was obtained and maintained throughout the manufacturing process. As will be further discussed hereafter, the high binding capacity particles provide improved performance in the immunochemical assay. In addition, since the particles are washed using water, instead of a flammable solvent, there is an improvement in the safety and wa~e disposal aspects of making the particles. Furthermore, the manufacturing efficiency and cost aspects are improved, since considerably ~-less silane (approximately one-fifth as much) is needed to manufacture the particles.
One discovery regarding the paramagnetic particles related to the fact that both the sodium hydroxide concentration and total concentration of ferrous chloride and ferric chloride used during the preparation of iron particles could affect particle size. Figure l, which shows particle siz as a function of total iron concentration at two levels of sodium hydroxide, shows that the use of higher NaOH concentration ~21~
would lead to larger iron particles. The particle size was determined by measuring the sedimentation rate for the particles. Throughout the experiment reported in Figure 1, the molar ratio of ferrous to ferric ions remained at 2:1, but the total iron concentration was varied. The results showed that as total iron concentration increased, particle size, as determined by sedimentation rate, increased. The variation of NaOH concentration was used to prepare iron core particles of desired siæe that would be used in the next step of the process, the silanization step.
It was also learned t~at the novel process was more efficient in silane utilization, in that a much higher concentration of silane was found to be deposited on the magnetic particles. Particles silanized at pH 11.0 were compared to those prepared using the former technique ~where the iron particles were prepared a~ pH 5.0), and the pH 11.0 - prepared particles were found to contain at :Least 5 times the silane content as those prepared at pH 5Ø (See Figure 2, which shows free amine content as a function of time, at two pH~s~ For the data in Figure 2, the SPDP method, to be discussed in more detail hereafter, was used to determine amine concentration on the particles. It should be noted ;~
that amine content was used as an indicator of silane content.) Thus to obtain equivalent silane content, much less silane is needed at pH 11Ø
The effect of p~ on silane amine deposit on the particles was determined by measuring the amount of stable primary amine on the particle. This was done by a new analytical technique using N-succinimidyl-3-(2-pyridyldithio3propionate (or SPDP), discussed in detail in Example 3. In the immunochemical analysis in which the magnetic particles are . . , 2~82~g~
used, it is advantageous for the particles to have more silane and, subsequently, more biologically active materials could be bound This higher capacity particle (shown vs.
reference material in Figure 2) was, there~ore, selected for use in the silanization, and, as can be seen in Figure 2, this resulted in more silane amines being immobilized on the particles.
In addition, the novel process represented an improvement in safety and environmental aspects because of the ability of using water as the solvent, as opposed to methanol in the previous manufacture technique.
The ratio of ferrous to ferric could vary, but preferably the ratio was equal to one or was greater than one.
Somewhat more preferred was the ratio of 1.0 to 3Ø Most preferably the ratio was equal to 2. At this ratio, the particle size was found to be dependent on the molarity of the NaOH used. It was also found that the strong magnetic property correlated to the color of the particle~. When the particles were ~lack, the strongest magnetic properties were 0 found, and the black color was found when the ratio of ~0--ferrous to ferrlc~exceeded one. (See Table 1) ~4~ ~
The silane that can be used to coat the particles can be any -' silane with one or more reactive groups per molecule. The general chemical structure of the preferred silane compound can be depicted as OR OR
Ro-si-~cH2)p~x or Ro-si- (CH2) q-Y- (CH2) p-X
OR OR
where R = methyl, ethyl, or propyl, and the R groups do not -~ 2~82~ 8~ ~
need to be the same in the same molecule. p can range ~rom 1 to 5 and q can rang~ from O to 5. X can be NH~, SH, Cl, ~o /01 CN, , -CH2-CH-CH2, or -O-CO-C~CH3)=CH2, and Y
can be NH, benzyl sr substituted benzyl, or oxygen.
Preerably the silane compound is one where p is between 1 and 3, where the R groups are the same within one molecule and where X is an amino group. The most preferred silanes are alkylamine silanes, such as N-2-aminoethyl-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, n-hexyltrimethoxylsilane, and n-dodecyltriethoxysilane. -The following examples describe various aspects of the preparation, analysis and use of the magnetizable particles described herein but are not intended to limit the usefulness of the newly invented materials or processes.
PREPARATION OF MAGNETIZABLE PARTICLES
A laboratory batch size of approximately 4 - 5 grams of particles were prepared. 98 ml of 0.5 M ferrous chloride and 9-8 ml of 0.25 M ferric chloride were mixed with 49 ml of distilled water in a 500 ml erlenmeyer flask. 49 ml of 5 M
NaOH pr~-warmed to 60 C. was poured into the iron chloride :. , .
~: . , - , , , ~
~$~
mixture while swirling. Black iron oxide particles were ormed instantly. The particles were precipitated by placing a strong magnet under the erlenmeyer, and the supernatent was decanted. The particles were then washed with 200 ml of an aqueous solution containing 0O05 M NaCl, and the supernatent was decanted and its pH measured. The NaCl washings were continued until the pH of the supernatent reached neutrality.
EX~MPLE 2 SILANIZATION OF THE PARTICLES
In a 500 ml, 3-arm, round bottom flask, 4 - 5 grams of the magnetizable particles from Example 1 were suspended in 150 ml of aqueous solution containing 2% by weight of alkylamine trimethoxy silane and 0~05 M NaCl. The pH of the mixture should be llo0~ A cooling condenser was placed in one side arm, a nitrogen gas intake was placed in the other side arm, ~ -while a paddle-stirrer was placed in the center arm. The flask was immersed half-way in a silicone oil bath at 90 -95 C. The reaction is allowed to proceed for 2 hours, with nitrogen set at 0.1 pounds per square inch pressure and with the stirrer rotating slowly. After the reaction was stopped, the particles were washed 5 times with 100 - 150 ml of an aqueous solution containing 0.05 M NaCl. The 2~2~
particles were then suspended in loO ml of 0.05 M NaCl solution and were ready f~r amine determination by the SPDP
method.
~XAMPLE 3 N-succinimidyl-3-(2-pyridyldithio)propionate (or SPDP) is used in a novel technique to determine amin~ content of the silanized particles. Duplicate "unknown" samples were run vs. duplicate non-silanized samples (controls), which were used to determine background readings. 3 - 4 mg of parti~les were washed with distilled water for 6 times and were resuspended in 1 ml of distilled water .in a 12 x 75 mm glass test tube. Duplicate samples were heated in a 100 C.
water bath ~or 0, 15, 30 and 60 minutes. All samples were washed again twie with water~ then s~spended in 1 ml of 0~1 M sodium phosphate buffer/0.15 M NaCl, at pH 8Ø Each sample was then transferred quantitatively into a 18x15Q mm glass test tube, to which is added 100 ~l of a solution of SPDP (5 mg/ml in ethanol). The samples are mixed well and -shaken at room temperature for 1 hour. Each sample was then washed 3 times with 1 ml of 0.01 M phosphate buffered saline (PBS) at pH 7.4 and then resuspended in 2 ml of the same PBS
buffer. To each sample was added 50 ~l Gf dithiothriotol '' ' ' -, ' .
' 2~21~
_9 _ solutio~ (10 mg/ml in the PBS buffer). 2-thiopyridine is then released quantitatively. tSee Figure 3.~ Nano-equivalent concentration of amine is calculated bas~d on the standard curve of 2-thiopyridine absorbance at 343 nm.
PARTICLE SIZE DETERMINATION
Particle size was determined by sedimentation kinetics in water, with the faster sedimentation rates indicating larger particle size. The sedimentation was determined by observing the change in optical density at 600 nm as a function of time. Optical density chanye over a period of about 4 ~inutes was measured, and the rate was calculated to be the change in O.D./time. Control lots made by the former method were used as controls. Typical data are sho~n in Figure 1.
PREPARATION OF MAGNETIC PARTICLES COUPLED TO ANTIBODY
To illustrate the preparation of magnetic particles coupled to antibody, the immobilization of antibody against thyroid stimulating hormone (TSH) is described.
~2~
110 mg of silanized particles were first heat treated at 100 C. for 30 minutes to remove unstable amine. They were then activated with 20 ml of 10~ glutaraldehyde in 0.1 M
sodium phosphate buffer, at p~ 7.4~ for 3 hours at room temperature. The particles were then washed three times with the same buffer and then resuspended in 10 ml of the same buffer containing 2~ mg of anti-rrSH immunoglo~ulin~
After mixing on a rocker overnight ~t room temperature, the supernatant was decanted, and the particles were suspended 10 in 10 ml of a solution containing 10 mg/ml of bovine serum albumin tBSA) in 0.1 M phosphate buffer, pH 7.4. ~he suspension was placed in a 50 C. water bath and shaken for 4 hours. Afte.r 3 washes with 0.1 M ~odium phosphate buf~er, pH 7.4, the particles were resuspended in 50 ml of the PBS/BSA buffer (0.01 M sodium phosphate, 0.15 M NaCl, 1 mg/ml bovine serum albumin, pH 7.4) and evaluated in the TSH
assay system.
USE OF COUPLED MAGNETIC PARTICLES IN IMMUNOCHEMICAL ASSAY
The coupled anti-TSH particles prepared in Example 5 were analyzed by their use in an immunochemical assay. ~uplicate samples were run and averaged to obtain each value.
.
':' : . , : ~ ' .
., ' - : . .
2~18~
loo ml of a sample containing a known amount of TSH was mixed in a flask with 100 ~1 of the coupled antibody prepared in Example 5 which was labeled with I~I. After 2 hours of incubation at room temperature, 500~1 of the solid phase antibody was added. The solution was stirred and then incubated further for 30 minutes at room tamperature. Then the solid phase was separated ~y placing a strong magnet under the flask. After the supernatent was decanted, the remaining particles were washed with 1 ml of water, and, after exposing to a magnet for 3 minutes, the supernatant was again decanted. The residue was then counted using radioisotope techniques. The same assay was run using the particles made by the foxmer manufacturing technique (PMP) as a control. ~he results are shown in Table 2. It was found that the particles made by the novel technigue ~HMP) gave lower non-specific binding. Bo~h sensitivity and slope of the standard curve using the novel technique were approximately doubled, the improvement being attributed to the higher amine content which led to improved coupling efficiency.
~4382.~g EFFECT OF FE~/FE~+
ON YIELD, PARTICLE SIZE, PARAMAG~ETISM, COLOR
RATIO YIELD SEDIMENTATION RATE PACKED COLOR
MIM ~lm~ In H~ In NaCl Solu OD~MIN VOL. RBL. DRY
1:1 80 4 5 1303E-3 2 BLK
1:2 35.6 5 4 1.25E-3 1 BRN
1:3 10.5 3 3 6.7E-3 3 BRN
2:1 68.3 1 1 12.5E-3 4 BLK
2:3 80.4 3 4 3.75E-3 3 BRN
PRODUC'~ION OF HIGH BINDING CAPACITY MAGNETIZABLE PARTIC~ES
OF CONTROLLED SIZE USED IN IM~NOASSAY SYSTEMS
Backaround The use of magnetic particles for biochemical separations has been known for some time. (U.S. Patents ~,554,088;
4,628,037; ~,695,392; 4,695,393; Hersh, L.S., Yaverbaum, S., Magnetic Solid-Phase Radioimmunoassay, 63 Clin. Chim. Acta (1975) 69; Pourfarzaneh, M., Johnson, S.C., Landon, J., Production and Use of ~agnetizable Particles in Immunoassay, 5 The ~igand Quarterly (~82~ 41.) They are particularly use~ul in the separation of immwlochemical complexes, in which one of the members of the immunochemical pair (i.e., either the antigen or antibody) is coupled to the magnetic particle. When this parti¢le complexes to the other member of the i~munochemical pair, the complex is then easily separated from the solution by the use of a ma~net.
The Whitehead patents co~er the coatPd iron oxide particles :~
themselves (U.S~ Patent No. 4,695,392), the particles coupled to a ~ioaffinity adsorbent ~U.S. Patent No~
4,S54,088), the use of the particles for determining the concentration of a ligate (U.S. Patent No. 4,628,037~, and the process for preparing the magnetically-responsive particles ~V~SO Patent No. 4,69S,393).
: ' The existing (Whitehead) process for preparing these 2~82:~g~
particles involves the use of acidic pH conditions (pH 4.5), to which a 10~ silane amine solution is added, with the mixture heated at 90 - ~5 QC for about 2 hours followed by a glycerol dehydration step and a wash of the final product with copious amounts of methanol and water. This results in a decrease in particle size and a corresponding decrease in sedimentation rate for the particles. ln addition, the existing process involves the use of hazardous solvents (e.g., methanol) and, therefore, requires the use of special facilities and equipment (to reduce the risk from possible explosion) and the need to take precautions regarding the disposal or recycling of the spent solvent.
Summary High binding capacity magnetized particles, which represent a significant improvament over the existing paramagnetic particles, were developed. It was found that the use of high pH silanization yields particles that maintain the original size throughout the manufacturing process. These exhi~it good binding capacity and do not require the use of hazardous solvents during manufacture. Also, it was found to be a more efficient process, in that an 80 - 90%
reduction in the use of silane was realized.
Details of the Invention This invention rslates to an improvement in the process for making paramagnetic particles which are useful in ~;
biochemical separations. One major use is in immunochemical assays, wherein a biochemically active species (e.g., an antibody) is chemically bound to the paramagnetic particle.
After the paramagnetic particle-antibody complex has reacted with any antigen in solution, the presence of the paramagnetic material simplifies the separation of the - . ~
2~2~
antigell-antibody complex for further analysis. Other applications, for example, in affinity purification chromatography, are known for these paramagnetic particles by those experienced in the art.
Although paramagnetic particles made of iron salts are prefPrred, particles made from any material or combination of materials having magnetic properties can be used in the novel process for making coated magnetic particles. For example, chromium salts or mixtures of iron salts and glass can be used in the process.
It was found that, by conducting the silanization process in a high pH environment, an unexpected benefit was found, in that relatively high binding capacity was obtained and maintained throughout the manufacturing process. As will be further discussed hereafter, the high binding capacity particles provide improved performance in the immunochemical assay. In addition, since the particles are washed using water, instead of a flammable solvent, there is an improvement in the safety and wa~e disposal aspects of making the particles. Furthermore, the manufacturing efficiency and cost aspects are improved, since considerably ~-less silane (approximately one-fifth as much) is needed to manufacture the particles.
One discovery regarding the paramagnetic particles related to the fact that both the sodium hydroxide concentration and total concentration of ferrous chloride and ferric chloride used during the preparation of iron particles could affect particle size. Figure l, which shows particle siz as a function of total iron concentration at two levels of sodium hydroxide, shows that the use of higher NaOH concentration ~21~
would lead to larger iron particles. The particle size was determined by measuring the sedimentation rate for the particles. Throughout the experiment reported in Figure 1, the molar ratio of ferrous to ferric ions remained at 2:1, but the total iron concentration was varied. The results showed that as total iron concentration increased, particle size, as determined by sedimentation rate, increased. The variation of NaOH concentration was used to prepare iron core particles of desired siæe that would be used in the next step of the process, the silanization step.
It was also learned t~at the novel process was more efficient in silane utilization, in that a much higher concentration of silane was found to be deposited on the magnetic particles. Particles silanized at pH 11.0 were compared to those prepared using the former technique ~where the iron particles were prepared a~ pH 5.0), and the pH 11.0 - prepared particles were found to contain at :Least 5 times the silane content as those prepared at pH 5Ø (See Figure 2, which shows free amine content as a function of time, at two pH~s~ For the data in Figure 2, the SPDP method, to be discussed in more detail hereafter, was used to determine amine concentration on the particles. It should be noted ;~
that amine content was used as an indicator of silane content.) Thus to obtain equivalent silane content, much less silane is needed at pH 11Ø
The effect of p~ on silane amine deposit on the particles was determined by measuring the amount of stable primary amine on the particle. This was done by a new analytical technique using N-succinimidyl-3-(2-pyridyldithio3propionate (or SPDP), discussed in detail in Example 3. In the immunochemical analysis in which the magnetic particles are . . , 2~82~g~
used, it is advantageous for the particles to have more silane and, subsequently, more biologically active materials could be bound This higher capacity particle (shown vs.
reference material in Figure 2) was, there~ore, selected for use in the silanization, and, as can be seen in Figure 2, this resulted in more silane amines being immobilized on the particles.
In addition, the novel process represented an improvement in safety and environmental aspects because of the ability of using water as the solvent, as opposed to methanol in the previous manufacture technique.
The ratio of ferrous to ferric could vary, but preferably the ratio was equal to one or was greater than one.
Somewhat more preferred was the ratio of 1.0 to 3Ø Most preferably the ratio was equal to 2. At this ratio, the particle size was found to be dependent on the molarity of the NaOH used. It was also found that the strong magnetic property correlated to the color of the particle~. When the particles were ~lack, the strongest magnetic properties were 0 found, and the black color was found when the ratio of ~0--ferrous to ferrlc~exceeded one. (See Table 1) ~4~ ~
The silane that can be used to coat the particles can be any -' silane with one or more reactive groups per molecule. The general chemical structure of the preferred silane compound can be depicted as OR OR
Ro-si-~cH2)p~x or Ro-si- (CH2) q-Y- (CH2) p-X
OR OR
where R = methyl, ethyl, or propyl, and the R groups do not -~ 2~82~ 8~ ~
need to be the same in the same molecule. p can range ~rom 1 to 5 and q can rang~ from O to 5. X can be NH~, SH, Cl, ~o /01 CN, , -CH2-CH-CH2, or -O-CO-C~CH3)=CH2, and Y
can be NH, benzyl sr substituted benzyl, or oxygen.
Preerably the silane compound is one where p is between 1 and 3, where the R groups are the same within one molecule and where X is an amino group. The most preferred silanes are alkylamine silanes, such as N-2-aminoethyl-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, n-hexyltrimethoxylsilane, and n-dodecyltriethoxysilane. -The following examples describe various aspects of the preparation, analysis and use of the magnetizable particles described herein but are not intended to limit the usefulness of the newly invented materials or processes.
PREPARATION OF MAGNETIZABLE PARTICLES
A laboratory batch size of approximately 4 - 5 grams of particles were prepared. 98 ml of 0.5 M ferrous chloride and 9-8 ml of 0.25 M ferric chloride were mixed with 49 ml of distilled water in a 500 ml erlenmeyer flask. 49 ml of 5 M
NaOH pr~-warmed to 60 C. was poured into the iron chloride :. , .
~: . , - , , , ~
~$~
mixture while swirling. Black iron oxide particles were ormed instantly. The particles were precipitated by placing a strong magnet under the erlenmeyer, and the supernatent was decanted. The particles were then washed with 200 ml of an aqueous solution containing 0O05 M NaCl, and the supernatent was decanted and its pH measured. The NaCl washings were continued until the pH of the supernatent reached neutrality.
EX~MPLE 2 SILANIZATION OF THE PARTICLES
In a 500 ml, 3-arm, round bottom flask, 4 - 5 grams of the magnetizable particles from Example 1 were suspended in 150 ml of aqueous solution containing 2% by weight of alkylamine trimethoxy silane and 0~05 M NaCl. The pH of the mixture should be llo0~ A cooling condenser was placed in one side arm, a nitrogen gas intake was placed in the other side arm, ~ -while a paddle-stirrer was placed in the center arm. The flask was immersed half-way in a silicone oil bath at 90 -95 C. The reaction is allowed to proceed for 2 hours, with nitrogen set at 0.1 pounds per square inch pressure and with the stirrer rotating slowly. After the reaction was stopped, the particles were washed 5 times with 100 - 150 ml of an aqueous solution containing 0.05 M NaCl. The 2~2~
particles were then suspended in loO ml of 0.05 M NaCl solution and were ready f~r amine determination by the SPDP
method.
~XAMPLE 3 N-succinimidyl-3-(2-pyridyldithio)propionate (or SPDP) is used in a novel technique to determine amin~ content of the silanized particles. Duplicate "unknown" samples were run vs. duplicate non-silanized samples (controls), which were used to determine background readings. 3 - 4 mg of parti~les were washed with distilled water for 6 times and were resuspended in 1 ml of distilled water .in a 12 x 75 mm glass test tube. Duplicate samples were heated in a 100 C.
water bath ~or 0, 15, 30 and 60 minutes. All samples were washed again twie with water~ then s~spended in 1 ml of 0~1 M sodium phosphate buffer/0.15 M NaCl, at pH 8Ø Each sample was then transferred quantitatively into a 18x15Q mm glass test tube, to which is added 100 ~l of a solution of SPDP (5 mg/ml in ethanol). The samples are mixed well and -shaken at room temperature for 1 hour. Each sample was then washed 3 times with 1 ml of 0.01 M phosphate buffered saline (PBS) at pH 7.4 and then resuspended in 2 ml of the same PBS
buffer. To each sample was added 50 ~l Gf dithiothriotol '' ' ' -, ' .
' 2~21~
_9 _ solutio~ (10 mg/ml in the PBS buffer). 2-thiopyridine is then released quantitatively. tSee Figure 3.~ Nano-equivalent concentration of amine is calculated bas~d on the standard curve of 2-thiopyridine absorbance at 343 nm.
PARTICLE SIZE DETERMINATION
Particle size was determined by sedimentation kinetics in water, with the faster sedimentation rates indicating larger particle size. The sedimentation was determined by observing the change in optical density at 600 nm as a function of time. Optical density chanye over a period of about 4 ~inutes was measured, and the rate was calculated to be the change in O.D./time. Control lots made by the former method were used as controls. Typical data are sho~n in Figure 1.
PREPARATION OF MAGNETIC PARTICLES COUPLED TO ANTIBODY
To illustrate the preparation of magnetic particles coupled to antibody, the immobilization of antibody against thyroid stimulating hormone (TSH) is described.
~2~
110 mg of silanized particles were first heat treated at 100 C. for 30 minutes to remove unstable amine. They were then activated with 20 ml of 10~ glutaraldehyde in 0.1 M
sodium phosphate buffer, at p~ 7.4~ for 3 hours at room temperature. The particles were then washed three times with the same buffer and then resuspended in 10 ml of the same buffer containing 2~ mg of anti-rrSH immunoglo~ulin~
After mixing on a rocker overnight ~t room temperature, the supernatant was decanted, and the particles were suspended 10 in 10 ml of a solution containing 10 mg/ml of bovine serum albumin tBSA) in 0.1 M phosphate buffer, pH 7.4. ~he suspension was placed in a 50 C. water bath and shaken for 4 hours. Afte.r 3 washes with 0.1 M ~odium phosphate buf~er, pH 7.4, the particles were resuspended in 50 ml of the PBS/BSA buffer (0.01 M sodium phosphate, 0.15 M NaCl, 1 mg/ml bovine serum albumin, pH 7.4) and evaluated in the TSH
assay system.
USE OF COUPLED MAGNETIC PARTICLES IN IMMUNOCHEMICAL ASSAY
The coupled anti-TSH particles prepared in Example 5 were analyzed by their use in an immunochemical assay. ~uplicate samples were run and averaged to obtain each value.
.
':' : . , : ~ ' .
., ' - : . .
2~18~
loo ml of a sample containing a known amount of TSH was mixed in a flask with 100 ~1 of the coupled antibody prepared in Example 5 which was labeled with I~I. After 2 hours of incubation at room temperature, 500~1 of the solid phase antibody was added. The solution was stirred and then incubated further for 30 minutes at room tamperature. Then the solid phase was separated ~y placing a strong magnet under the flask. After the supernatent was decanted, the remaining particles were washed with 1 ml of water, and, after exposing to a magnet for 3 minutes, the supernatant was again decanted. The residue was then counted using radioisotope techniques. The same assay was run using the particles made by the foxmer manufacturing technique (PMP) as a control. ~he results are shown in Table 2. It was found that the particles made by the novel technigue ~HMP) gave lower non-specific binding. Bo~h sensitivity and slope of the standard curve using the novel technique were approximately doubled, the improvement being attributed to the higher amine content which led to improved coupling efficiency.
~4382.~g EFFECT OF FE~/FE~+
ON YIELD, PARTICLE SIZE, PARAMAG~ETISM, COLOR
RATIO YIELD SEDIMENTATION RATE PACKED COLOR
MIM ~lm~ In H~ In NaCl Solu OD~MIN VOL. RBL. DRY
1:1 80 4 5 1303E-3 2 BLK
1:2 35.6 5 4 1.25E-3 1 BRN
1:3 10.5 3 3 6.7E-3 3 BRN
2:1 68.3 1 1 12.5E-3 4 BLK
2:3 80.4 3 4 3.75E-3 3 BRN
3:1 57.5 2 3 6.2.5E-3 3 BLK
3:2 68.0 2 2 6.25E-3 3 BLK
Relative values, with 2-1 set at l All wet cakes appear to be black. When dried, they appear either black or brown in color~
Significant particle loss during washing steps 2~2.1l~ ~
COMPARISON OF RIA TSH SENSITIVITY BETWEEN PMP AND HMP
AS SOLID SUPPORT FOR TSH ANTIBODY
STANDARD
_8~ L_ ~ 2~1Ekl HMPL2MG/ML) HMP(lMG/ML~. HMPt.5MGLML) 0.751,01~ 1,031 803 611 2 1,952 1,96~ 1,535 1,138 6 4,264 4,901 3,667 2,610 ~,443 9,245 7,248 5,410 3~ 13,668 15,12~ 11,865 8,~89 60 22,023 23,619 19,132 13,738 SENSITIVITY
2.97 4.10 6.64 6.7 MAX. SIGNAL/
NOISE R~TIO
64.21 94.10 15~.12 152.64 (All values are means of duplicate samples. No overlappingg readings between two adjacent standards.) PMP are particles made at pH5. HNP are particles made at pHll.
As measured by reading of 0.75 ~IU standard vs. that of 0.
As measured by reading of 60 ~IU standard vs. that of 0.
3:2 68.0 2 2 6.25E-3 3 BLK
Relative values, with 2-1 set at l All wet cakes appear to be black. When dried, they appear either black or brown in color~
Significant particle loss during washing steps 2~2.1l~ ~
COMPARISON OF RIA TSH SENSITIVITY BETWEEN PMP AND HMP
AS SOLID SUPPORT FOR TSH ANTIBODY
STANDARD
_8~ L_ ~ 2~1Ekl HMPL2MG/ML) HMP(lMG/ML~. HMPt.5MGLML) 0.751,01~ 1,031 803 611 2 1,952 1,96~ 1,535 1,138 6 4,264 4,901 3,667 2,610 ~,443 9,245 7,248 5,410 3~ 13,668 15,12~ 11,865 8,~89 60 22,023 23,619 19,132 13,738 SENSITIVITY
2.97 4.10 6.64 6.7 MAX. SIGNAL/
NOISE R~TIO
64.21 94.10 15~.12 152.64 (All values are means of duplicate samples. No overlappingg readings between two adjacent standards.) PMP are particles made at pH5. HNP are particles made at pHll.
As measured by reading of 0.75 ~IU standard vs. that of 0.
As measured by reading of 60 ~IU standard vs. that of 0.
Claims (16)
1. A process for making a coated magnetic particle comprising reacting a suspension of the particles with silane in alkaline pH conditions.
2. The process of claim 1 wherein the particles are iron oxide particles.
3. The process of claim 1 wherein the alkaline pH is approximately pH 11.
4. The process of claim 2 in which the ratio of ferrous to ferric particles is equal to or greater than l.
5. The process of claim 4 in which the ratio is equal to or greater than 1.0 and less than 3Ø
6. The process of claim 5 in which the ratio is equal to 2.
7. The process of claim 1 in which the silane has the formula or where R = methyl, ethyl, or propyl, and the R groups do not need to be the same in the same molecule, p can range from 1 to 5, q can range from 0 to 5, and X can be NH2, SH, Cl, CN, , , - O-CO -C(CH3)=CH2.
8. The process of claim 7 where p is between 1 and 3, the R groups are the same within 1 molecule, and X is NH2.
9. The process of claim 8 in which the silane is an alkylamine silane.
10. The process of claim 9 in which the silane is N-2-aminoethyl-3-aminopropyltrimethoxysilane.
11. The particles produced by the process of claim 1.
12. The process of using the particles of claim 11 in an immunochemical assay.
13. The process of claim 12 which comprises the coupling of the particles with a bioaffinity adsorbent prior to its use in the immunochemical assay.
14. The process of claim 13 in which the bioaffinity adsorbent is either an antigen or antibody.
15. A method for analysis of stable amines comprising the use of N-succinimidyl-3-(2-pyridyldithio)propionate.
16. A method of claim 15 comprising (a) reacting the amine with N-succinimidyl-3-(2-pyridyldithio)propionate, (b) reacting the isolated product from step (a) with dithiothreitol, thus releasing 2-thiopyridine, and (c) comparing the absorbance of the solution resulting from step (b) with a standardized curve to determine the concentration of amine.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86639392A | 1992-04-10 | 1992-04-10 | |
| US866,393 | 1992-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2082186A1 true CA2082186A1 (en) | 1993-10-11 |
Family
ID=25347513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2082186 Abandoned CA2082186A1 (en) | 1992-04-10 | 1992-11-05 | Production of high binding capacity magnetizable particles of controlled size used in immunoassay systems |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2082186A1 (en) |
-
1992
- 1992-11-05 CA CA 2082186 patent/CA2082186A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0125995B1 (en) | Magnetic particles for use in separations | |
| US4695392A (en) | Magnetic particles for use in separations | |
| US4695393A (en) | Magnetic particles for use in separations | |
| US4698302A (en) | Enzymatic reactions using magnetic particles | |
| US4628037A (en) | Binding assays employing magnetic particles | |
| US5773307A (en) | Method and device for determining an analyte in a sample | |
| CA1304421C (en) | Affinity separating using immobilized flocculating reagents | |
| Mehta et al. | Direct binding of protein to magnetic particles | |
| US5571726A (en) | Kit containing glutaraldehyde coated colloidal metal particles of a preselected size | |
| US4278651A (en) | Supported receptor and use thereof in an assay | |
| CA1314769C (en) | Magnetically responsive particles and method of preparation | |
| CA1118344A (en) | Bridging the sulphur atom of antigen, antibody or fragments to a substrate | |
| CA1111762A (en) | Fluorescent rare earth chelate in polymeric latex particles | |
| IE75725B1 (en) | Ligand gold bonding | |
| WO1993010162A1 (en) | Production and use of magnetic porous inorganic materials | |
| JPS6338668B2 (en) | ||
| EP0506880A1 (en) | Organo-metallic coated particles for use in separations | |
| WO1990015666A1 (en) | Coated magnetic particles for use in separations | |
| JP2619917B2 (en) | How to measure protein | |
| IE62737B1 (en) | A method of determining in a test sample one or more components of the reaction between a specifically-binding protein and the corresponding bindable substance, using a least one labelled component, a method of preparing the labelled component, and a test kit for the determination of immuno components | |
| AU687033B2 (en) | Undercoating of solid phase surfaces and direct coating method | |
| CA2082186A1 (en) | Production of high binding capacity magnetizable particles of controlled size used in immunoassay systems | |
| Huang et al. | Effect of fluorochrome location in protein A on sensing efficiency of IgG | |
| Zelikman et al. | Protein immunoassay based on agglutination of antibody-coated ferric oxide particles | |
| Rongsen et al. | Magnetic microparticle antibodies and their application to RIAs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |